Contents of this document
- Structural improvements, including workforce rightsizing in Europe
- Sale of the European automotive aftermarket glass installation business
- End of production at the UK site of Integrated Chemicals
- Sale of the Colorado site of the biopharmaceutical CDMO business
- Strengthening Automotive's manufacturing and technology management structure
- Capacity expansion for electronic materials, fluorine-related products and biopharmaceutical CDMO operations
- D/E ratio0.4 times
- ROCE_Architectural Glass5.2 %
- ROCE_Automotive8.5 %
- ROCE_Electronics8.2 %
- ROCE_Chemicals7 %
- ROCE_Life Science-9.3 %
- ROCE_Ceramics and Other10.4 %
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | Q3 FY2026 |
| Net Sales | ¥16,626 hundred million (YoY +9.9%) |
| Operating profit | ¥929 hundred million (YoY -2.0%) |
| Net income | ¥334 100 million (net income attributable to owners of the parent) (YoY -15.4%) |
| Operating profit margin | 5.6 % (YoY -0.7%) |
| Results for the three months of the current quarter | Net Sales ¥5,620 hundred million / Operating profit ¥282 hundred million |
| Full-year earnings forecast | Net Sales ¥22,000 hundred million / Operating profit ¥1,200 hundred million / Business profit ¥900 hundred million / Pretax profit ¥820 hundred million / Profit attributable to owners of the parent ¥400 hundred million / Dividend per share ¥210 / Operating profit margin 5.5 % / ROE 2.7 % |
| Progress against full-year forecast | Consolidated total Net Sales 74 % / Operating profit 77 % / Architectural Glass Net Sales 73 % / Operating profit 86 % / Automotive Net Sales 76 % / Operating profit 91 % / Electronics Net Sales 75 % / Operating profit 74 % / Chemicals Net Sales 73 % / Operating profit 80 % / Life Science Net Sales 72 % / Ceramics and Other Net Sales 65 % / Operating profit 74 % |
| Self-assessment against the plan | Operating profit and other items were revised downward because Automotive, Essential Chemicals Southeast Asia, Architectural Glass and Life Science are expected to underperform assumptions. |
| Segment results | Architectural Glass Net Sales 3,372 / Operating profit 94 / Year-on-Year Change in Revenue (%) 5.1 / Operating profit year-on-year_pct -6 / Automotive Net Sales 4,176 / Operating profit 154 / Year-on-Year Change in Revenue (%) 8.3 / Operating profit year-on-year_pct -34.2 / Electronics Net Sales 2,708 / Operating profit 339 / Year-on-Year Change in Revenue (%) 4.3 / Operating profit year-on-year_pct -5.8 / Chemicals Net Sales 5,157 / Operating profit 437 / Year-on-Year Change in Revenue (%) 19.6 / Operating profit year-on-year_pct 10.3 / Life Science Net Sales 1,002 / Operating profit -126 / Year-on-Year Change in Revenue (%) 4.3 / Operating profit year-on-year_pct 22.2 / Ceramics and Other Net Sales 389 / Operating profit 30 / Year-on-Year Change in Revenue (%) -7.2 / Operating profit year-on-year_pct 57.9 |
| Breakdown of Factors Affecting the Change | Operating profit YoY Effect of the weaker yen, higher shipments of chemicals and electronic materials, price increases, higher raw material and fuel prices, and higher manufacturing costs / Other income and expenses Architectural Glass business structural improvement costs -52 / Gain on sale of shares in automotive affiliates 105 / Chemical Products business structural improvement costs -101 / Loss on sale of life sciences fixed assets -104 / Change in full-year operating profit from the initial forecast Essential Chemicals Southeast Asia -10 / Automotive -150 / Architectural Glass -90 / Life Science -80 |
| Key KPIs | Indicator name D/E ratio / Value 0.4 times / Year on year against the same period last year Not disclosed, Indicator name ROCE_Architectural Glass / Value 5.2 % / Year on year against the same period last year Not disclosed, Indicator name ROCE_Automotive / Value 8.5 % / Year on year against the same period last year Not disclosed, Indicator name ROCE_Electronics / Value 8.2 % / Year on year against the same period last year Not disclosed, Indicator name ROCE_Chemicals / Value 7 % / Year on year against the same period last year Not disclosed, Indicator name ROCE_Life Science / Value -9.3 % / Year on year against the same period last year Not disclosed, Indicator name ROCE_Ceramics and Other / Value 10.4 % / Year on year against the same period last year Not disclosed |
| Unit price and quantity metrics | Year-on-year changes in volume and price or volume are provided for architectural glass, automobile production and display panel demand. |
| Number of employees | The European automotive aftermarket glass installation business has just over 300 employees, while the UK site has just over 200. |
| Assumptions Underlying the Business Outlook | 1USD ¥160.0 / 1EUR ¥180.0 / Dubai crude oil 100.0 USD/BBL / Foreign exchange sensitivity A 1% depreciation of the yen increases operating profit by ¥500 million. / Crude oil price sensitivity A US$1 increase reduces operating profit by ¥260 million. |
| Financial targets | Full-year forecast ROE 2.7 % / D/E ratio at end-September 2026 0.4 % / D/E unit times |
| Annual Dividend | Annual ¥210 / Interim and year-end Not disclosed |
| Payout ratio | 58 % |
| Acquisition of treasury shares | Undecided for 2026. No details have been disclosed regarding the purchase amount, number of shares or period. |
| Capital expenditures | ¥1,398 100 million (cumulative January–third quarter 2026) |
| New initiatives | Structural improvements, including workforce rightsizing in Europe, Sale of the European automotive aftermarket glass installation business, End of production at the UK site of Integrated Chemicals, Sale of the Colorado site of the biopharmaceutical CDMO business, Strengthening Automotive's manufacturing and technology management structure, Capacity expansion for electronic materials, fluorine-related products and biopharmaceutical CDMO operations |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue growth was driven by the effect of the weaker yen, higher shipments of chemicals and electronic materials, and price increases in Integrated Chemicals and Architectural Glass Europe. Factors behind the decline in profit were higher raw material and fuel prices, deteriorating manufacturing costs, and lower productivity in Automotive Europe and North America and other businesses. The full-year forecast was revised downward due to higher costs in Automotive and Essential Chemicals Southeast Asia, volume shortfalls in Architectural Glass and Life Science, and higher other expenses.